BioCryst Pharmaceuticals, Inc.
BCRX stock score: 60/100
$7.88 · +3.01% · Scored Oct 26, 2026
- Technical
- 39
- Fundamental
- 81
- News
- 54
The reading
BioCryst Pharmaceuticals (BCRX) scores 60 out of 100, which reads neutral, higher than 86% of Healthcare stocks and 73% of the 4,151 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 39, fundamentals 81.
Among the fundamentals, Return on Invested Capital (ROIC) at 100 and Price Target at 100 score highest, while Profit Margins at 0 weighs the most against it.
On the daily chart, trend-following indicators average 26 and contrarian oscillators 67 — a split worth reading before trusting the technical total.
News sentiment is neutral at 54; it is shown, not counted in the composite.
Since Jul 29, 2026 the composite has ranged from 58 to 78, and it is down 18 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward BCRX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
81Pulling it up
- Return on Invested Capital (ROIC)100
Return on Invested Capital measures the operating profit a company earns on all the capital invested in it, debt and equity alike.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Return on Assets (ROA)100
Return on Assets (ROA) shows how efficiently a company uses its assets to generate profit.
Holding it back
- Profit Margins0
Profit margins show what percentage of revenue becomes profit.
- Fund Ownership0
Fund ownership tracks institutional investor holdings and changes.
- PEG Ratio0
PEG ratio divides the P/E ratio by earnings growth rate.
37 weighted scorers; 4 had no data today and are left out rather than counted as zero.
Technical · daily
30Pulling it up
- Williams %R (28)86
Williams %R (28-period) places the close within the last 28 periods' high-low range.
- Williams %R (14)81
Williams %R (14-period) measures where the current price sits within the recent high-low range.
- RSI (14)78
Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.
Holding it back
- Ichimoku Cloud0
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 502
Simple Moving Average (50-period) is a widely-watched intermediate-term trend gauge.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 54
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 55 | 1 |
| Daily | 30 | 3 |
| Weekly | 35 | 2 |
| Monthly | 45 | 2 |
| Quarterly | 42 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 26, 2026 | 60 |
| Oct 25, 2026 | 58 |
| Oct 24, 2026 | 58 |
| Oct 23, 2026 | 58 |
| Oct 22, 2026 | 58 |
| Oct 21, 2026 | 59 |
| Oct 20, 2026 | 61 |
| Oct 19, 2026 | 61 |
| Oct 18, 2026 | 59 |
| Oct 17, 2026 | 58 |
| Oct 16, 2026 | 59 |
| Oct 15, 2026 | 61 |
| Oct 14, 2026 | 61 |
| Oct 13, 2026 | 62 |
| Oct 12, 2026 | 66 |
| Oct 11, 2026 | 67 |
| Oct 10, 2026 | 67 |
| Oct 9, 2026 | 67 |
| Oct 8, 2026 | 64 |
| Oct 7, 2026 | 64 |
| Oct 6, 2026 | 61 |
| Oct 5, 2026 | 63 |
| Oct 4, 2026 | 61 |
| Oct 3, 2026 | 62 |
| Oct 2, 2026 | 62 |
| Oct 1, 2026 | 61 |
| Sep 30, 2026 | 63 |
| Sep 29, 2026 | 63 |
| Sep 28, 2026 | 63 |
| Sep 27, 2026 | 67 |
| Sep 26, 2026 | 67 |
| Sep 25, 2026 | 67 |
| Sep 24, 2026 | 67 |
| Sep 23, 2026 | 67 |
| Sep 22, 2026 | 68 |
| Sep 21, 2026 | 68 |
| Sep 20, 2026 | 65 |
| Sep 19, 2026 | 65 |
| Sep 18, 2026 | 66 |
| Sep 17, 2026 | 66 |
| Sep 16, 2026 | 64 |
| Sep 15, 2026 | 61 |
| Sep 14, 2026 | 61 |
| Sep 13, 2026 | 61 |
| Sep 12, 2026 | 61 |
| Sep 11, 2026 | 61 |
| Sep 10, 2026 | 62 |
| Sep 9, 2026 | 66 |
| Sep 8, 2026 | 69 |
| Sep 7, 2026 | 74 |
| Sep 6, 2026 | 74 |
| Sep 5, 2026 | 74 |
| Sep 4, 2026 | 74 |
| Sep 3, 2026 | 74 |
| Sep 2, 2026 | 75 |
| Sep 1, 2026 | 75 |
| Aug 31, 2026 | 72 |
| Aug 30, 2026 | 73 |
| Aug 29, 2026 | 74 |
| Aug 28, 2026 | 74 |
| Aug 27, 2026 | 74 |
| Aug 26, 2026 | 73 |
| Aug 25, 2026 | 74 |
| Aug 24, 2026 | 72 |
| Aug 23, 2026 | 72 |
| Aug 22, 2026 | 72 |
| Aug 20, 2026 | 72 |
| Aug 19, 2026 | 73 |
| Aug 18, 2026 | 73 |
| Aug 17, 2026 | 73 |
| Aug 16, 2026 | 72 |
| Aug 15, 2026 | 73 |
| Aug 14, 2026 | 72 |
| Aug 13, 2026 | 73 |
| Aug 12, 2026 | 74 |
| Aug 11, 2026 | 74 |
| Aug 10, 2026 | 73 |
| Aug 9, 2026 | 70 |
| Aug 8, 2026 | 71 |
| Aug 7, 2026 | 70 |
| Aug 6, 2026 | 61 |
| Aug 5, 2026 | 61 |
| Aug 3, 2026 | 59 |
| Aug 2, 2026 | 60 |
| Jul 31, 2026 | 74 |
| Jul 30, 2026 | 76 |
| Jul 29, 2026 | 78 |
Key facts
- Market cap
- $2.0B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Beta
- 0.55
- Risk grade (1–10)
- 8
- Next earnings
- Nov 4, 2026
Drug Manufacturers - Specialty & Generic peers
| Company | Market cap | Score |
|---|---|---|
| RGC Regencell Bioscience Holdings | $3.4B | 29 |
| HCM HUTCHMED (China) | $2.5B | 55 |
| BHC Bausch Health Companies | $2.4B | 56 |
| SUPN Supernus Pharmaceuticals | $2.4B | 43 |
| PBH Prestige Consumer Healthcare | $2.3B | 47 |
| PRGO Perrigo Company | $2.2B | 42 |
Questions
What is BCRX's stock score today?
BCRX scores 60/100 (Neutral) as of Oct 26, 2026: technical 39, fundamental 81, and news sentiment 54, which is shown but not counted. Scores are recomputed every night.
Is BCRX a buy?
The score is not a buy or sell recommendation. A 60 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the BCRX score calculated?
98 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.